Mcdonald Partners »

Vaneck Vectors Pharmaceutical etf shares owned by Mcdonald Partners

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Mcdonald Partners from 13F filings

Historical chart of Mcdonald Partners investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Mcdonald Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Mcdonald Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 325 109.35

More positions owned by Mcdonald Partners

Eaton Corp SHS (ETN)
Lumentum Hldgs (LITE)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Raytheon Technologies Corp (RTX)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Us Gwt (IUSG)
Amgen (AMGN)
Abbvie (ABBV)

View all positions for Mcdonald Partners

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Jane Street
Healthcare Of Ontario Pension Plan Trust Fund
Bnp Paribas Arbitrage, Snc
British Columbia Investment Management Corporation
Employees Retirement System of Texas
Royal Bank of Canada
J.Safra Asset Management
Tower Research Capital
Avalon Trust
Citigroup
Gts Securities
Morgan Stanley
Adamsbrown Wealth Consultants
Bank of America Corporation

View all funds holding Vaneck Vectors Pharmaceutical etf